Suppr超能文献

客观评估光学治疗对视差性弱视中大细胞和小细胞优势视觉反应的影响。

Objective Assessment of the Effect of Optical Treatment on Magnocellular and Parvocellular-biased Visual Response in Anisometropic Amblyopia.

机构信息

,.

出版信息

Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):21. doi: 10.1167/iovs.61.2.21.

Abstract

PURPOSE

Optical treatment can improve visual function in anisometropic amblyopia, but there is no electrophysiological evidence, and the underlying change in visual pathway remains unknown. Our aims were to characterize the functional loss in magnocellular and parvocellular visual pathways in anisometropic amblyopia at baseline and to investigate the effect of optical treatment on the 2 visual pathways.

METHODS

Using isolated-check visual-evoked potential, we measured the magnocellular- and parvocellular-biased contrast response functions in 15 normal controls (20.13 ± 3.93 years; mean ± standard deviation), 16 patients with anisometropic amblyopia (18.00 ± 6.04 years) who were fully refractive corrected before and 29 (19.41 ± 7.41 years) who had never been corrected. Twelve previously uncorrected amblyopes received optical treatment for more than 2 months and finished the follow-up measurement.

RESULTS

Both the magnocellular- and parvocellular-biased contrast response functions in the amblyopic eye exhibited significantly reduced response and weaker contrast gains. We also found that the uncorrected amblyopes showed a more severe response reduction in magnocellular-biased, but not parvocellular-biased condition when compared with those corrected, with a weaker initial contrast gain and lower maximal response. After optical treatment, 12 uncorrected amblyopes demonstrated improved visual acuity of the amblyopic eye and a significant response gain to magnocellular-biased but not parvocellular-biased stimuli.

CONCLUSIONS

We demonstrated deficits to both magnocellular- and parvocellular-biased stimuli in subjects with anisometropic amblyopia. Optical treatment could produce neurophysiological changes in visual pathways even in older children and adults, which may be mediated through the magnocellular pathway.

摘要

目的

光学治疗可改善屈光参差性弱视的视觉功能,但尚无电生理证据,视觉通路的潜在变化仍不清楚。我们的目的是在基线时描述屈光参差性弱视中大细胞和小细胞视通路的功能丧失,并研究光学治疗对 2 种视通路的影响。

方法

使用分离检查视觉诱发电位,我们测量了 15 名正常对照者(20.13±3.93 岁;平均值±标准差)、16 名屈光参差性弱视患者(18.00±6.04 岁,在完全矫正屈光不正之前)和 29 名从未矫正过的患者的大细胞和小细胞优势对比反应功能。12 名未经矫正的弱视患者接受了超过 2 个月的光学治疗,并完成了随访测量。

结果

弱视眼的大细胞和小细胞优势对比反应功能均表现出明显的反应降低和较弱的对比增益。我们还发现,与矫正者相比,未经矫正的弱视者在大细胞优势条件下表现出更严重的反应降低,但在小细胞优势条件下则不然,其初始对比增益较弱,最大反应较低。经过光学治疗后,12 名未经矫正的弱视患者的弱视眼视力明显提高,对大细胞优势刺激的反应增益显著,但对小细胞优势刺激的反应增益则不显著。

结论

我们在屈光参差性弱视患者中发现了对大细胞和小细胞优势刺激的缺陷。即使在年龄较大的儿童和成人中,光学治疗也能产生视觉通路的神经生理变化,这可能是通过大细胞通路介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38d2/7326570/710f6ec3b8bd/iovs-61-2-21-f001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验